kyron.bio today announced a €5.5M Seed Round

The seed funding round was led by HCVC, with the participation of Verve Ventures, Entrepreneur First, Saras Capital, and numerous reputable angel investors. 

The funds will accelerate the development of kyron.bio’s proprietary glycan-engineering platform, expand the kyron.bio team and fuel preclinical studies.